Enterobacteriaceae with bla NDM-7 is relatively uncommon and had previously been described in Europe, India, USA and Japan. This study describes the characteristics of Enterobacteriaceae Epidemiological and molecular studies are required to better understand the dynamics of transmission, risk factors and reservoirs for bacteria harboring bla . To the best of our knowledge, this is the first report of S. marcescens, and E. hormaechei with bla 2
Introduction
The metallo-β-lactamase, NDM-1 was first described in Klebsiella pneumoniae and Echerichia coli recovered from a Swedish patient who was previously hospitalized in New Delhi, India (1) . Subsequently, bacteria with NDM have been recognized in over 50 countries on every continent, except Antarctica (2) . Gram negative bacteria with bla NDMs are endemic in South Asia (especially the Indian Subcontinent), South-East Asia (3, 4) and certain countries within the Middle East and the Balkans (5). Infections with NDM-producing bacteria in nonendemic areas such as Europe and North America, have most often been associated with patients who required hospitalization while visiting an endemic area (6).
NDM carbapenemases are commonly reported in K. pneumoniae and E. coli, but also have been found in a variety of other members of the Enterobacteriaceae, including Acinetobacter spp., Pseudomonas spp. and Vibrio cholerae (7, 8) . The treatment of infections caused by multidrug resistant NDM-producing Enterobacteriaceae is causing serious therapeutic challenges for the medical community because isolates are often also resistant to non-β-lactam antibiotics (9). Bacteria with NDMs often remain only susceptible to agents, such colistin, fosfomycin and tigecycline (10).
During 2013 and 2014, six Enterobacteriaceae with bla NDM-7 were isolated from four different Calgary patients over a period of 18 months. One patient was recently hospitalized in India, while the remaining three did not have a history of recent travel outside Alberta, Canada. NDM-7 is an infrequent bla NDM allele; therefore, a study was designed to characterize these isolates and their respective plasmids, using traditional and next generation sequencing techniques.
Materials and methods

Patient and isolates.
For a summary of the clinical features of patients 1-4 and time line of events, please see Table 1 and Figure 1 .
The isolates were identified using the MALDI-TOF MS (Vitek AMS; bioMerieux Vitek Systems Inc., Hazelwood, MO). Further identification of E. cloacae was performed by partial sequencing of the leuS gene (11).
Antimicrobial susceptibilities. Minimum inhibitory concentrations (MICs) were determined using the Microscan NEG 38 panel (Siemens, Burlington, Ontario, Canada) and interpreted by using CLSI guidelines for broth dilution (12). The following drugs were tested:
gentamicin (GEN), tobramycin (TOB), ciprofloxacin (CIP), tigecycline (TGC) and trimethoprim-sulfamethoxazole (SXT). Colistin (COL), fosfomycin (FOS), imipenem (IPM), MEM, ERT MICs were determined using E-tests (bioMerieux Inc., Hazelwood, MO, United States) according to the manufacturer's instructions. The IPM, MEM, ERT, FOS E-tests were also performed on the E. coli J53 transcongugants (see below). The European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpoint was used for COL and the FDA breakpoint was used for TGC.
Carbapenemase gene identification. The presence of carbapenemases was detected using the CLSI guidelines for the modified Hodge test (MHT) and the MASTDISCS™ ID inhibitor combination disks (13) (Mast Group Ltd., Merseyside, United Kingdom). PCR undertaken using primers and conditions as previously described (13).
Plasmid analysis. Plasmid sizes were determined as previously described (14) and assigned to plasmid incompatibility (Inc) groups by PCR-based replicon typing (15) (16) (17) .
Conjugation experiments were performed by mating-out assays with nutrient agar containing MEM 1µg/ml and using E. coli J53 (azide 100 μg/ml) as recipient. Plasmids from the transconjugants were sequenced using Pacific Biosciences RSII platform (Menlo Park, CA, USA) and Illumina MiSeq system (San Diego, CA, USA) [see details below].
Multilocus sequencing typing (MLST).
MLST on the K. pneumoniae (18) , E. coli (19) , and E. cloacae (20) were performed as previously described.
Complete sequencing of bla NDM-7 -harboring plasmids. The genome of isolate KpN01 from patient 1 (chromosome and plasmids) were sequenced using Pacific Biosciences RSII platform (Menlo Park, CA, USA). Assembly of the data was performed using the Hierarchical Genome Assembly Process (HGAP) compiled specifically for quality trimming, de novo assembly and polishing of PacBio data. The bla NDM-7 -harbouring plasmids from isolate SmN01
(from patient 2), EcN01 (from patient 2), EclcN01 (from patient 3), EcN02 (from patient 3) and KpN12 (from patient 4) were sequenced using a previously described method (21) . In brief, plasmid DNA from E. coli J53 transconjugants with a single bla NDM-7 -harboring plasmid was extracted using a Qiagen Plasmid Maxi kit (Qiagen, Valencia, CA), and sequenced using Illumina MiSeq system (San Diego, CA, USA). Sequencing reads were de novo assembled into consensus contigs using Velvet algorithms (22) , and sequence gaps were closed by PCR and standard Sanger sequencing. The resultant plasmids were annotated using the Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP) available at NCBI (http://www.ncbi.nlm.nih.gov/). The plasmid replicon type (InC) was examined by
PlasmidFinder (23), and antibiotic resistance genes were identified with the Comprehensive Antibiotic Resistance Database (CARD) (24) . The plasmids were compared to each other and then compared to publicly available plasmid references using BLAST at GenBank.
(ncbi.nlm.nih.gov/genbank/). The plasmid comparison and visualization were generated by Easyfig (25) according to the online protocol (http://easyfig.sourceforge.net/).
Nucleotide sequence accession number. The complete nucleotide sequence of pKpN01-NDM-7 was deposited as GenBank accession no. CP012990.
Results and Discussion
Susceptibilities, and carbapenemase genes. Table 2 shows the susceptibilities of the clinical isolates. EclcN01 was identified as Enterobacter hormaechei. All the isolates tested positive with the modified Hodge test, and the MASTDISCS™ ID inhibitor combination disks indicated that they all were MBL-producers. All of the isolates were positive for bla  according to PCR and sequencing results ( Table 2) .
Enterobacteriaceae with bla NDM-7 are relatively uncommon, having only been previously described in E. coli from France (26), Germany (27) , India (28), USA (29) and Japan (30), and K. pneumoniae from the USA (29), Spain (31) and Denmark (32) . The single biggest risk factor in all patients was a history of recent travel to India with two exceptions; the French case previously travelled to Burma, while no connection with the Indian subcontinent was established among the Spanish patients (26, 31) . One of the Calgary patients (patient no 2) recently visited India (although he had no contact with the health-care system in that country to the best of our >16  >16  >16  >16  CRO  >32  >32  >32  >32  >32  >32  CAZ  >16  >16  >16  >16  >16  >16  FEP  >16  >16  >16  >16  >16  >16  ATM  >16  ≤4  >16  >16  >16  >16  MEM  >8  >8  >8  >8  >8  >8  ERT  >4  >4  >4  >4  >4  >4 
piperacillin-tazobactam (TZP), cefoxitin (FOX), ceftriaxone (CRO), ceftazidime (CAZ), cefepime (FEP), aztreonam (ATM), meropenem (MEM), ertapenem (ERT), Imipenem (IPM), amikacin (AMK), gentamicin (GEN), tobramycin (TOB), ciprofloxacin (CIP), tigecycline (TGC). Fosfomycin (FOS), trimethoprim-sulfamethoxazole (SXT), colistin (COL), modified Hodge test (MHT), Multilocus sequencing typing (MLST), Minimum inhibitory concentration (MIC), metallo-β-lactamase (MBL).
knowledge), and the remaining patients (patients 1, 3, 4) had no recent history of travel outside Alberta. The cases were not linked by time or place, and we were unable to establish any epidemiological linkage between the four patients. The patients from hospital A were admitted to different wards over different time periods and stayed in different parts of Calgary.
Plasmids and MLST.
MLST showed that KpN01 belonged to ST278, EcN01 to ST44, EclcN01 to ST113, EcN02 to ST91 and KpN12 belonged to ST138 ( Table 1 ). The isolates contained several plasmids with different sizes, but interestingly, they all harboured a plasmid of approximately 50 kb ( Table 1 ). The transconjugants obtained with the different isolates (i.e.,
KpN01T, SmN01T etc.) contained the 50kb plasmid, which was positive for bla NDM and typed with the IncX3 replicon ( Table 1 ). The international case reports of E. coli with bla belonged to various sequence types including ST167 from France (26), ST599 from Germany (27) , ST617 from the USA (29) and ST648 from Japan (30).The K. pneumoniae from the USA and Denmark were typed as ST147 (29, 32) while the Spanish isolates belonged to ST437 (31) .
The conjugative plasmid with the bla NDM-7 from the French isolate was untypeable (26) and bla NDM-7 from the German E. coli was flanked upstream by IS5, ISAba125, downstream by ble MBL and located on a 60kb IncX3 plasmid (27) .
Plasmid sequencing and comparative plasmid analysis. The bla NDM-7 harboring plasmid in KpN01 (namely pKpN01-NDM7) is 46,161 bp in size with an average GC content of 46.6 %, and contains 54 predicted ORFs (Figure 2 ). The complete sequencing of bla NDM-7 -harboring plasmids from the other five transconjugants (i.e. SmN01T, EcN01T, EclcN01T, EcN02T and KpN12T) interestingly showed 100% identities to that of pKpN01-NDM7. This suggests that the same bla NDM-7 -containing plasmid was horizontally transferred to several different Enterobacteriaceae genera that colonized/infected the patients in the Calgary region.
Alternatively, there could have been common connections with patients from endemic settings who harbored the same or a closely related plasmid. However, we were unable to establish such a link.
pKpN01-NDM7 is a plasmid of IncX3 that are usually self-transferable and have been associated with the spread of several antimicrobial resistant genes, including carbapenemase genes, such as bla NDM (33) (34) (35) (36) (37) , bla KPC (38) , and bla OXA-181 (39, 40) . A BLAST search against the GenBank sequence database revealed that pKpN01-NDM7 is highly similar to other bla NDMharboring IncX3 plasmids, including pNDM-HN380 (bla NDM-1 ) (36), p112298-NDM (bla NDM-1 , KP987216), pEc1929 (bla NDM-5 , KT824791), pNDM_MGR194 (bla NDM-5 ) (34), pJEG027
(bla NDM-4 ) (35) and pOM26-1 (bla NDM-7 , KP776609) ( Figure 2 ). pKpN01-NDM7 has a typical backbone of IncX plasmids, including the genes encoding replication (pir and bis), partitioning (par), maintenance (topB and hns), and conjugal transfer (pil and tax) (17, 41) . Similar to other IncX3 plasmids, pKpN01-NDM7 carries three putative origins of replication (oriV-α, -β or -γ), and two origins of conjugal transfer (oriT-α and -β) (41) (42) (43) [ Figure 1 ]. The backbone regions amongst these bla NDM -harboring IncX3 plasmids showed very high identities (> 99.7% when compared with each other), suggesting they likely evolved from the same ancestor plasmid.
Common to other IncX3 plasmids, the bla NDM-7 -containing accessory region in pKpN01-NDM7, was located downstream of the serine resolvase gene, res. bla NDM-7 was carried by an IS26-dsbC-trpF-ble MBL -bla NDM-7 -ΔISAba125-IS5-ΔISAba125 genetic element; the same structure as the bla NDM-4 and bla NDM-5 containing elements reported previously (34, 35) , as well as being similar to the bla NDM-7 plasmid described from Germany (27) . The overall plasmid genome synteny in pKpN01-NDM7 is also identical to that of bla NDM-5 -harboring pNDM_MGR194
(from an ST11 K. penumoniae in India) (34) and bla NDM-4 -harboring pJEG027 (from a K.
pneumoniae isolate in Australia) (35) . Importantly, an IS5 was inserted into ISAba125 located upstream of bla NDM , leading to the interruption of ISAba125 into two segments (1,018 bp and 73 bp) (Figure 1 ). Downstream from bla NDM are the genes for ble MBL (encoding bleomycin-resistant protein), trpF, dsbC gene and an IS26 element.
There are two main differences between pKpN01-NDM7, pNDM_MGR194 and pJEG027. Firstly, they carry different bla NDM alleles; pKpN01-NDM7carried bla NDM-7 , while pJEG027 and pNDM_MGR194 harbored bla NDM-4 and bla NDM-5 , respectively. Of note, bla and bla NDM-5 each differs from bla NDM-4 by a single nucleotide (G388A and G262T, respectively). Secondly, pKpN01-NDM7 (46,161 bp) is 92 bp shorter than pNDM_MGR194 and pJEG027 (both are 46,253 bp). This is due to an extra 92 bp palindromic sequence in pNDM_MGR194 and pJEG027 that is upstream of taxD, which forms an additional oriT-β site.
It is not clear whether this extra oriT-β will enhance plasmid transfer efficiency, because a previous study indicated that the IncX plasmid can simultaneously cleave multiple nic sites thereby initiating conjugal transfer (42) . In addition, pKpN01-NDM7 also showed high identity to a bla NDM-7 bearing plasmid pOM26-1 (KP776609), isolated from an E. coli isolate in Oman.
pOM26-1 differs from pKpN01-NDM7 by a 1,039-bp deletion, encompassing the aforementioned 1,018 bp ΔISAba125 flanked by two 4-bp repeats (CTAA) (Figure 2 ). This suggests that pOM26-1 evolved from the pKpN01-NDM7-like plasmid as a result of ~1 Kb ΔISAba125-bearing element deletion. pNDM_MGR194 (bla NDM-5 ) may have also evolved from pJEG027 by accumulation of an additional mutation (G262T). Our study suggested that pKpN01-NDM7 had arisen from a pJEG027-like plasmid (bla NDM-4 -carrying) through acquisition of a different mutation (G388A), and that pOM26-1 is descendant from pKpN01-NDM7 through a ~1 Kb deletion.
In summary, this study describes the characteristics of Enterobacteriaceae with bla isolated from 4 Canadian patients from Calgary, Alberta without apparent epidemiological linkages. The 46,161 bp IncX3 plasmid with bla NDM-7 is highly similar to other bla NDM -harboring IncX3 plasmids. The NDM-7 containing plasmids from this study, interestingly, showed identical structures within the different Enterobacteriaceae isolates (i.e. K. pneumoniae, E. coli.
occurred previously between these patients or there were connections with patients from endemic settings that we were unable to establish. To the best of our knowledge, this is the first report of S. marcescens, and E. hormaechei with bla NDM-7.
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